Cargando…

A FIRST REPORT ON OUTCOMES OF STEREOTACTIC BODY RADIOTHERAPY FOR POSTERIOR ELEMENT ONLY SPINAL METASTASES AND VALIDATION OF RECOMMENDED CLINICAL TARGET VOLUME DELINEATION PRACTICE

Spine stereotactic body radiotherapy (SBRT) improves local control and pain response compared to conventional external beam radiotherapy. Consensus stipulates MRI-based delineation of the clinical target volume (CTV) and is based on spine segment sector involvement. The applicability to metastases l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burgess, Laura, Zeng, K Liang, Myrehaug, Sten, Soliman, Hany, Tseng, Chia-Lin, Detsky, Jay, Chen, Hanbo, Palhares, Daniel Moore, Witiw, Christopher D, Zhang, Beibei, Maralani, Pejman, Sahgal, Arjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337566/ http://dx.doi.org/10.1093/noajnl/vdad071.015

Ejemplares similares

STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SACRAL METASTASES: DEVIATION FROM RECOMMENDED TARGET VOLUME DELINEATION PREDICTS HIGHER RISK OF LOCAL FAILURE
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

BIOMARKER STATUS PREDICTS FOR LOCAL CONTROL (LC) FOLLOWING SPINE STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH SPINAL METASTASES
por: Shor, Dana, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
por: Zeng, K Liang, et al.
Publicado: (2021)

RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA: AN ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL AND PREDICTORS OF RADIATION NECROSIS
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

CLINICAL APPLICATION OF SATURATION TRANSFER MRI FOR DIFFERENTIATING TUMOUR PROGRESSION FROM RADIATION NECROSIS IN BRAIN METASTASES
por: Chan, Rachel W, et al.
Publicado: (2023)

Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain Metastasis
por: Karami, Elham, et al.
Publicado: (2019)

Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution
por: Tseng, Chia-Lin, et al.
Publicado: (2017)

Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy
por: Chang, Joe H., et al.
Publicado: (2016)

Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy
por: Stewart, James, et al.
Publicado: (2023)

LOCL-16 IMPACT OF MGMT PROMOTER METHYLATION STATUS ON TUMOR DYNAMICS DURING WEEKLY ADAPTIVE RADIOTHERAPY FOR GLIOBLASTOMA
por: Hudson, John M, et al.
Publicado: (2022)

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)

Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases
por: Mehrabian, Hatef, et al.
Publicado: (2019)

Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
por: Ruschin, Mark, et al.
Publicado: (2017)

High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report
por: Tseng, Chia-Lin, et al.
Publicado: (2022)

Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy
por: Mehrabian, Hatef, et al.
Publicado: (2018)

Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin Dose
por: Wang, Michael H., et al.
Publicado: (2022)

Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis
por: Stewart, James, et al.
Publicado: (2022)

ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma
por: Maralani, Pejman Jabehdar, et al.
Publicado: (2021)

Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma
por: Maralani, Pejman Jabehdar, et al.
Publicado: (2021)

Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow
por: Tseng, Chia-Lin, et al.
Publicado: (2020)

A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning
por: Jaberipour, Majid, et al.
Publicado: (2021)

Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

PREDICTORS OF TUMOR DYNAMICS DURING A COURSE OF 30-FRACTION RADIOTHERAPY FOR GLIOBLASTOMA
por: Ong, W L, et al.
Publicado: (2023)

Improved dosimetric accuracy with semi‐automatic contour propagation of organs‐at‐risk in glioblastoma patients undergoing chemoradiation
por: Lee, Sangjune, et al.
Publicado: (2019)

Non Tumor Perfusion Changes Following Stereotactic Radiosurgery to Brain Metastases
por: Jakubovic, Raphael, et al.
Publicado: (2015)

Hypofractionated Stereotactic Radiotherapy in Five Daily Fractions for Post-Operative Surgical Cavities in Brain Metastases Patients with and without Prior Whole Brain Radiation
por: Al-Omair, Ameen, et al.
Publicado: (2013)

Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
por: Vellayappan, Balamurugan, et al.
Publicado: (2018)

Predicting response to radiotherapy of intracranial metastases with hyperpolarized [Formula: see text] C MRI
por: Lee, Casey Y., et al.
Publicado: (2021)

Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases
por: Spencer, Katie L, et al.
Publicado: (2019)

BEVACIZUMAB FOR SYMPTOMATIC RADIATION NECROSIS IN BRAIN METASTASES: OUTCOMES FROM A SINGLE-CENTER RETROSPECTIVE ANALYSIS
por: Roberto, Katrina, et al.
Publicado: (2023)

Chemical Exchange Saturation Transfer MRI: What Neuro-Oncology Clinicians Need To Know
por: Jabehdar Maralani, Pejman, et al.
Publicado: (2023)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

To frame or not to frame? Cone‐beam CT‐based analysis of head immobilization devices specific to linac‐based stereotactic radiosurgery and radiotherapy
por: Babic, Steven, et al.
Publicado: (2018)

A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery
por: Liu, Yan, et al.
Publicado: (2017)

Impact of Tumour Segmentation Accuracy on Efficacy of Quantitative MRI Biomarkers of Radiotherapy Outcome in Brain Metastasis
por: Jalalifar, Seyed Ali, et al.
Publicado: (2022)

Predicting the outcome of radiotherapy in brain metastasis by integrating the clinical and MRI‐based deep learning features
por: Jalalifar, Seyed Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v61jao2sbcs0mmsjbdk1ivrcv1